A 28-year-old woman comes to the clinic reporting a 4-month history of progressively worsening fatigue, intermittent abdominal bloating, and loose, foul-smelling stools. She has a past medical history of type 1 diabetes mellitus, which is well managed with a basal-bolus insulin regimen. Her vital signs are within normal limits. Physical examination reveals conjunctival pallor and mild abdominal distension without focal tenderness. Laboratory studies show a hemoglobin of 10.2 g/dL, a mean corpuscular volume of 74 fL, and a serum ferritin of 8 ng/mL. Which of the following is the most appropriate next step in laboratory evaluation?
- Measurement of tissue transglutaminase IgA and total serum IgAAnswer
- BMeasurement of tissue transglutaminase IgA and anti-endomysial IgA
- CMeasurement of deamidated gliadin peptide IgG and tissue transglutaminase IgG
- DHuman leukocyte antigen DQ2 and DQ8 genotyping
- EMeasurement of fecal calprotectin and qualitative stool fat
Answer
Measurement of tissue transglutaminase IgA and total serum IgA
The correct sequence for establishing a diagnosis of celiac disease begins with recognizing the high clinical suspicion in this patient with type 1 diabetes, chronic diarrhea, and iron deficiency anemia. The most appropriate initial laboratory step is testing for tissue transglutaminase (tTG) IgA antibodies, which offer excellent sensitivity and specificity. However, it is a critical requirement to concurrently measure total serum IgA levels. Patients with celiac disease have a significantly higher prevalence of selective IgA deficiency compared to the general population. If total IgA is not measured, an IgA-deficient patient will yield a false-negative tTG IgA result, leading to a missed diagnosis. If total IgA is found to be deficient, the laboratory evaluation must pivot to IgG-based testing, such as deamidated gliadin peptide (DGP) IgG.
Step-by-Step Solution
Key Concept
Initial laboratory screening for celiac disease requires measurement of tissue transglutaminase (tTG) IgA alongside total serum IgA to prevent false-negative interpretation in patients with concurrent selective IgA deficiency.
Estimated Time:1m 15s